VLP Therapeutics was featured in Nikkei Biotech Online (February 4, 2015).
VLP Therapeutics, Inc. ("VLP"), a Rockville-based biotechnology company focusing on the research and development of next generation antibody agents and therapeutic as well as preventive vaccines based upon a novel and proprietary i-αVLP technology (which stands for "inserted alpha virus like particle"), today announced that Ryuji Ueno, M.D., Ph.D., Ph.D., Co-Founder and former Chair, Chief Executive Officer and Chief Scientific Officer of Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) ("Sucampo") will join VLP as Chair and Chief Medical Officer, effective today.
Dr. Akahata was featured in Nihon Keizai Shinbun Evening Edition (March 4, 2014).
Dr. Akahata was featured in Yomiuri Shinbun, Kakeru (February 20, 2014).
Co-Founder, Dr. Kuno was featured in Asahi Shinbun Globe (November 17, 2013).
VLP Therapeutics was featured in Asahi Shinbun (August 11, 2011).